US20030044941A1 - Human RNase III and compositions and uses thereof - Google Patents

Human RNase III and compositions and uses thereof Download PDF

Info

Publication number
US20030044941A1
US20030044941A1 US10/079,185 US7918502A US2003044941A1 US 20030044941 A1 US20030044941 A1 US 20030044941A1 US 7918502 A US7918502 A US 7918502A US 2003044941 A1 US2003044941 A1 US 2003044941A1
Authority
US
United States
Prior art keywords
method
rnase iii
polypeptide
polynucleotide
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/079,185
Inventor
Stanley Crooke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/659,440 priority Critical patent/US5898031A/en
Priority to US08/870,608 priority patent/US6107094A/en
Priority to US47978300A priority
Priority to US09/900,425 priority patent/US6737512B2/en
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Priority to US10/079,185 priority patent/US20030044941A1/en
Assigned to ISIS PHARMACEUTICALS, INC. reassignment ISIS PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CROOKE, STANLEY T.
Publication of US20030044941A1 publication Critical patent/US20030044941A1/en
Application status is Abandoned legal-status Critical

Links